GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Last update: 12 Oct, 9:31PM

71.01

-3.21 (-4.32%)

  • 1D -4.32%
  • 5D -10.57%
  • 1M -7.07%
  • 6M 5.84%
  • YTD -9.40%
  • 1Y -18.17%
  • 5Y 18.35%
Previous Close 74.22
Open 74.01
Volume 7,015,446
Avg. Volume (3M) 3,622,695
Market Cap 32,420,472,832
Price / Earnings (TTM) 14.55
Price / Earnings (Forward) 16.69
Price / Sales 1.77
Price / Book 3.61
52 Weeks Range
57.65 (-18%) — 94.80 (33%)
Earnings Date 29 Oct 2025
TTM Dividend Yield 0.20%
Profit Margin 11.03%
Operating Margin (TTM) 14.78%
Diluted EPS (TTM) 4.76
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 50.80%
Total Debt/Equity (MRQ) 97.51%
Current Ratio (MRQ) 0.980
Operating Cash Flow (TTM) 1.78 B
Levered Free Cash Flow (TTM) 1.58 B
Return on Assets (TTM) 5.87%
Return on Equity (TTM) 26.44%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bullish Mixed
Health Information Services (Global) Bullish Mixed
Stock GE HealthCare Technologies Inc. Bullish Bearish

AIStockmoo Score

1.1
Analyst Consensus 3.0
Insider Activity NA
Price Volatility 1.0
Technical Moving Averages 2.5
Technical Oscillators -2.0
Average 1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GEHC 32 B 0.20% 14.55 3.61
TEM 16 B - 43.00 50.12
HQY 8 B - 57.60 3.60
WAY 7 B - 56.90 2.30
RCM 6 B - - 2.14
BTSG 6 B - 60.72 2.92

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Sector Healthcare
Industry Health Information Services
Investment Style Mid Core
% Held by Insiders 0.28%
% Held by Institutions 80.26%
52 Weeks Range
57.65 (-18%) — 94.80 (33%)
Price Target Range
80.00 (12%) — 92.00 (29%)
High 92.00 (Evercore ISI Group, 29.56%) Buy
Median 86.50 (21.81%)
Low 80.00 (Morgan Stanley, 12.66%) Hold
Average 86.17 (21.35%)
Total 3 Buy, 3 Hold
Avg. Price @ Call 73.86
Firm Date Target Price Call Price @ Call
Evercore ISI Group 30 Oct 2025 92.00 (29.56%) Buy 75.00
Morgan Stanley 30 Oct 2025 80.00 (12.66%) Hold 75.00
Wells Fargo 30 Oct 2025 87.00 (22.52%) Buy 75.00
BTIG 13 Oct 2025 89.00 (25.33%) Buy 71.84
Barclays 13 Oct 2025 86.00 (21.11%) Hold 71.84
Citigroup 07 Oct 2025 83.00 (16.88%) Hold 74.49

No data within this time range.

  • 3M
Date Type Details
03 Nov 2025 Announcement GE HealthCare management to present at upcoming investor conference
29 Oct 2025 Announcement GE HealthCare reports third quarter 2025 financial results
21 Oct 2025 Announcement Carevance platform expands access to GE HealthCare’s clinical excellence with advanced patient monitoring and new perioperative hypotension management capability
20 Oct 2025 Announcement GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care
14 Oct 2025 Announcement GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
13 Oct 2025 Announcement University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
09 Oct 2025 Announcement GE HealthCare unveils Carestation 850 at ANESTHESIOLOGY 2025: its next-generation anesthesia delivery system designed to adapt to care needs
01 Oct 2025 Announcement GE HealthCare to announce third quarter 2025 results on October 29, 2025
25 Sep 2025 Announcement GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025
24 Sep 2025 Announcement GE HealthCare announces cash dividend for third quarter of 2025
10 Sep 2025 Announcement GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
08 Sep 2025 Announcement GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
29 Aug 2025 Announcement GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency
28 Aug 2025 Announcement GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
21 Aug 2025 Announcement GE HealthCare management to present at upcoming investor conferences
Show more
TTM Dividend Yield 0.20%
2Y Average Dividend Yield 0.13%
Payout Ratio 2.63%
Expected Next Dividend Payment Feb 2026
Ex Date Announcement Date Payment Date Details
24 Oct 2025 24 Sep 2025 14 Nov 2025 0.035 Cash
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Cash
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Cash
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Cash
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Cash
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Cash
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Cash
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Cash
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Cash
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Cash
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2025 0.140 4 0.20
2024 0.120 4 0.15
2023 0.090 3 0.12

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria